InvestorsHub Logo
Followers 116
Posts 1882
Boards Moderated 0
Alias Born 11/22/2017

Re: longfellow95 post# 227672

Thursday, 05/16/2019 6:02:35 PM

Thursday, May 16, 2019 6:02:35 PM

Post# of 709713

It's about time they got Sawston licensed and up and running.



More evidence here:

Article 13th February 2019:


The growing UK Cell and Gene Therapy Market

https://www.conciliumsearch.com/insights/growing-uk-cell-and-gene-therapy-market

It is locations such as the UK that will help ensure these new therapies become more affordable, stable and accessible in the future.

Looking ahead this year, there are already plans secured for significant facilities expansion throughout the UK (primarily from companies such as Advent BioServices, Cell and Gene Therapy Catapult and Cobra Biologics), with an additional 1500m2 of clean room space (representing an approximate 20% overall increase) scheduled to become active before the end 2019.

Since 2017, there has been a 60% increase in the UK’s GMP licensing facilities. This all demonstrates the UK is well positioned to continue strengthening its global position in this complex market.



Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News